Tag:
Pfizer
Latest Headlines
Latest Headlines
E.U. panel recommends Inlyta for adults with kidney cancer
E.U. regulators have recommended Pfizer's kidney cancer drug Inlyta be approved for use in patients who don't respond to other medications.
FDA panel mixed on Pfizer's rare disease drug
Pfizer's pioneering rare-disease drug tafamidis garnered mixed reviews from FDA advisers Thursday, casting further uncertainty over whether the agency will green-light the treatment for the U.S. market.
UPDATED: Pfizer's David Simmons joins PPD as new CEO and chairman
David Simmons, a former Pfizer executive and general manager, will join Pharmaceutical Product Development as its new Chairman and CEO June 4.
Pfizer taps new emerging markets chief as Simmons exits
Olivier Brandicourt, who currently heads up Pfizer's primary care unit, will take over the job June 1.
Pfizer brings Lipitor brand to mobile app stores
Pfizer has decided to boost the profile of Lipitor in the digital realm, partnering with EatingWell magazine on a Lipitor-branded mobile app that includes 200 heart-healthy recipes that complement treatment with Pfizer's pill.
Pfizer adds healthy-eating app to Lipitor marketing arsenal
The drugmaker teamed up with EatingWell magazine to develop a mobile app, dubbed Recipes 2 Go, and a sister website, lipitorsmartliving.com. The mobile app hooks into Pfizer's Lipitor co-pay card offer with a feature that makes refills easier.
Fired Pfizer rep sues, claiming pregnancy-related discrimination
A Pfizer sales rep has sued the company, saying she was fired because of her pregnancy, Pharmalot reports.
UPDATED: In rare slap, FDA review rips up Pfizer's case for tafamidis
After considering the trial's failure to meet its co-primary endpoints and questioning the data gathered at 8 sites, the agency is recommending that the experts gathering to discuss the drug's fate on Thursday reject the therapy.
Pfizer recalls 653,000 bottles of smelly Advil
Recalls stink. At least Pfizer's did. In March, the company ($PFE) voluntarily pulled more than 650,000 bottles of Advil gel tabs from stores because because they had a strong odor, according to a notice on the FDA website.
UPDATED: Pfizer recalled 653,000 bottles of smelly Advil
In March, the company pulled more than 650,000 bottles of Advil gel tabs from stores because because they had a strong odor, according to a notice on the FDA website.
